Sapient Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
ONB
GIM
RG
Sapient Capital's LLY Position: Q2 2026 in Review
Sapient Capital increased its Eli Lilly (LLY) stake by 0.22% in Q2 2026, buying an estimated $3.25M and bringing the position to 1,447,540 shares worth $1.74B. The position accounts for 22.72% of the portfolio, ranked #1.
Sapient Capital first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sapient Capital held 1,447,540 shares of Eli Lilly worth $1.74B as of Q2 2026.
- Sapient Capital bought 3,185 Eli Lilly shares in Q2 2026, an estimated $3.25M.
- Eli Lilly made up 22.72% of Sapient Capital's portfolio in Q2 2026, its #1 holding.
- Sapient Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.